Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant- Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.381
https://www.valueinhealthjournal.com/article/S1098-3015(15)02457-2/fulltext
Title :
Acromegaly Patients with Inadequate Response to Maximum Dose Octreotide-Lar Who Progress to Treatment with Pegvisomant- Economic Evaluation and Incremental Budget Impact Analysis from the Public Perspective to São Paulo State
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)02457-2&doi=10.1016/j.jval.2015.09.381
First page :
A842
Section Title :
Research Podium Presentations - Session 1
Open access? :
No
Section Order :
2606